MedTrace Logo

Bovine Colostrum to Prevent Absorption of Gluten

NCT05555446 · Status: SUSPENDED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-12-04

No results posted yet for this study

Summary

To investigate the use of hyperimmune bovine colostrum to reduce gluten absorption.

A double-blind, cross-over study will be performed in which persons who are following a strict gluten-free diet will be challenged with oral gluten with or without the bovine colostrum.

Conditions

Interventions

DIETARY_SUPPLEMENT

Bovine colostrum

Subject will receive bovine colostrum with gluten.

DIETARY_SUPPLEMENT

Placebo

Subject will receive a placebo with gluten.

Sponsors & Collaborators

Principal Investigators

  • Jocelyn Silvester, MD PhD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-22
Primary Completion
2025-01-01
Completion
2025-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05555446 on ClinicalTrials.gov